Intrinsiqs

Is Encompass Health Corporation overvalued?

Encompass Health Corporation (EHC) looks overvalued — trading about 24% above its fair value.

Overvalued
Current price $140.99 Fair value $107.46
Price
$140.99
Fair value
$107.46
Current P/E
24.8
Normal P/E
18.9
Market cap
$13.83B
Dividend yield
0.5%
Return on equity
25.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares EHC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.